CYNTHIA SUTTER: Open Payments
NPI 1134681208 · SLATINGTON, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,788 in 72 payments from 10 companies in 2025. Trend: 2023 $1,536 · 2024 $1,495 · 2025 $1,788
Food & beverage: $1,788
| Company | Payments | Amount |
|---|---|---|
| Alkermes, Inc. | 16 | $470 |
| ABBVIE INC. | 18 | $316 |
| Neurocrine BioSciences, Inc. | 7 | $213 |
| Lundbeck LLC | 8 | $205 |
| Takeda Pharmaceuticals U.S.A., Inc. | 11 | $161 |
| Otsuka America Pharmaceutical, Inc. | 3 | $140 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $125 |
| Janssen Pharmaceuticals, Inc | 4 | $89 |
| Teva Pharmaceuticals USA, Inc. | 2 | $36 |
| Supernus Pharmaceuticals, Inc. | 2 | $34 |
Products named: ARISTADA, VRAYLAR, REXULTI, INGREZZA, TRINTELLIX, LYBALVI, CAPLYTA, INVEGA SUSTENNA.
Industry payments across PA — which companies pay providers there.
